Similarly, the median alanine transaminase level of the well-controlled type 2 diabetes mellitus group (14 (8–30) U/L) was not significantly different from that of the poorly controlled type 2 diabetes mellitus group (13 (7–34) U/L), (p = 0.37). The gene discussed is GPT; the disease is type 2 diabetes mellitus.